Nifty

:

18696.10

Sensex

:

62868.50

-116.40 (-0.62%)
-415.69 (-0.66%)

Login

Nifty
Sensex

:
:

18696.10
62868.50

-116.40 (-0.62%)
-415.69 (-0.66%)

TTK Healthcare Ltd.

Pharmaceuticals & Drugs - Global

Rating :

61/99

BSE: 507747 | NSE: TTKHLTCARE

Watchlist

NSE BSE

910.05

02-Dec-2022

Day's Open
Day's High
Day's Low
Previous Close

933.50
942.05
906.00
928.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

6538
60.17
990.35
622.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,311.58
45.79
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,058.45
1.08%
1.42

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.60
0.74
-2.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

0.81
-12.49
-5.05

PAT CAGR (%)

10 Years
5 Years
3 Years

2.69
0.37
14.53

P:E (Median)

8 Years
5 Years
3 Years

37.30
37.81
35.25

P:BV (Average)

8 Years
5 Years
3 Years

3.01
3.01
3.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.63
16.78
16.38

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 169.79 150.48 12.83% 192.62 131.37 46.62% 158.67 139.03 14.13% 212.49 179.19 18.58%
Expenses 165.80 147.85 12.14% 188.86 125.28 50.75% 153.99 129.50 18.91% 195.38 167.38 16.73%
EBITDA 3.99 2.63 51.71% 3.76 6.08 -38.16% 4.68 9.53 -50.89% 17.11 11.81 44.88%
EBIDTM 2.35% 1.75% 1.95% 4.63% 2.95% 6.85% 8.05% 6.59%
Other Income 11.06 3.02 266.23% 9.86 3.64 170.88% 5.21 3.37 54.60% 4.47 2.53 76.68%
Interest 0.80 0.37 116.22% 2.71 0.46 489.13% 0.97 0.49 97.96% 1.49 0.35 325.71%
Depreciation 3.32 3.11 6.75% 3.20 3.19 0.31% 3.12 3.19 -2.19% 3.32 3.37 -1.48%
PBT 10.94 4.65 135.27% 7.72 6.08 26.97% 5.80 9.22 -37.09% 16.77 10.63 57.76%
Tax 3.02 0.91 231.87% 3.38 1.70 98.82% 1.58 2.12 -25.47% 4.61 2.94 56.80%
PAT 7.91 3.75 110.93% 4.34 4.38 -0.91% 4.22 7.10 -40.56% 12.17 7.69 58.26%
PATM 4.66% 2.49% 2.25% 3.33% 2.66% 5.11% 5.72% 4.29%
EPS 5.61 2.66 110.90% 3.08 3.10 -0.65% 3.00 5.04 -40.48% 8.63 5.45 58.35%

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 733.57 599.24 476.06 645.77 627.88 577.55 527.81 518.87 482.93 416.18 382.30 Net Sales Growth 22.25% 25.87% -26.28% 2.85% 8.71% 9.42% 1.72% 7.44% 16.04% 8.86% Cost Of Goods Sold 347.45 281.50 209.32 260.02 262.59 241.59 243.44 229.27 219.45 194.45 189.59 Gross Profit 386.12 317.75 266.73 385.75 365.29 335.95 284.37 289.59 263.48 221.72 192.71 GP Margin 52.64% 53.03% 56.03% 59.73% 58.18% 58.17% 53.88% 55.81% 54.56% 53.28% 50.41% Total Expenditure 704.03 577.40 456.74 617.47 578.33 535.00 489.32 478.40 453.38 396.48 362.15 Power & Fuel Cost - 15.83 13.44 15.00 13.56 12.57 7.36 6.54 5.62 7.02 5.72 % Of Sales - 2.64% 2.82% 2.32% 2.16% 2.18% 1.39% 1.26% 1.16% 1.69% 1.50% Employee Cost - 102.84 93.70 143.94 130.70 120.12 87.99 81.42 72.28 60.66 52.95 % Of Sales - 17.16% 19.68% 22.29% 20.82% 20.80% 16.67% 15.69% 14.97% 14.58% 13.85% Manufacturing Exp. - 18.79 15.38 17.80 14.85 13.76 11.60 9.61 5.35 4.58 4.02 % Of Sales - 3.14% 3.23% 2.76% 2.37% 2.38% 2.20% 1.85% 1.11% 1.10% 1.05% General & Admin Exp. - 37.35 27.03 58.55 54.37 53.47 50.20 51.02 48.17 42.78 37.04 % Of Sales - 6.23% 5.68% 9.07% 8.66% 9.26% 9.51% 9.83% 9.97% 10.28% 9.69% Selling & Distn. Exp. - 115.03 91.90 114.58 94.84 87.32 83.91 96.35 97.94 82.19 69.12 % Of Sales - 19.20% 19.30% 17.74% 15.10% 15.12% 15.90% 18.57% 20.28% 19.75% 18.08% Miscellaneous Exp. - 6.08 5.97 7.59 7.42 6.16 4.81 4.18 4.57 4.79 69.12 % Of Sales - 1.01% 1.25% 1.18% 1.18% 1.07% 0.91% 0.81% 0.95% 1.15% 0.97% EBITDA 29.54 21.84 19.32 28.30 49.55 42.55 38.49 40.47 29.55 19.70 20.15 EBITDA Margin 4.03% 3.64% 4.06% 4.38% 7.89% 7.37% 7.29% 7.80% 6.12% 4.73% 5.27% Other Income 30.60 16.33 9.93 8.78 7.75 7.57 5.73 5.59 6.57 6.12 6.74 Interest 5.97 3.24 1.71 3.27 3.38 4.73 3.11 3.33 3.64 2.99 2.54 Depreciation 12.96 12.58 13.02 14.38 14.67 15.24 11.92 7.21 6.14 3.17 2.72 PBT 41.23 22.35 14.52 19.42 39.26 30.15 29.18 35.53 26.33 19.67 21.62 Tax 12.59 6.33 -14.16 7.11 14.89 11.98 10.44 12.86 10.18 7.28 7.42 Tax Rate 30.54% 25.48% -62.60% 36.61% 37.93% 39.73% 35.78% 36.19% 38.66% 37.01% 34.32% PAT 28.64 18.51 36.78 12.32 24.37 18.17 18.74 22.67 16.16 12.39 14.20 PAT before Minority Interest 28.64 18.51 36.78 12.32 24.37 18.17 18.74 22.67 16.16 12.39 14.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.90% 3.09% 7.73% 1.91% 3.88% 3.15% 3.55% 4.37% 3.35% 2.98% 3.71% PAT Growth 24.96% -49.67% 198.54% -49.45% 34.12% -3.04% -17.34% 40.28% 30.43% -12.75% EPS 20.31 13.13 26.09 8.74 17.28 12.89 13.29 16.08 11.46 8.79 10.07

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 329.63 294.65 248.99 251.43 232.97 157.47 136.21 118.27 106.93 98.22 Share Capital 14.13 14.13 14.13 14.13 14.13 7.77 7.77 7.77 7.77 7.77 Total Reserves 315.50 280.52 234.86 237.30 218.84 149.70 128.45 110.50 99.16 90.46 Non-Current Liabilities 1.08 4.41 6.55 2.43 2.24 7.73 16.37 27.87 27.23 11.26 Secured Loans 0.00 0.00 0.00 0.33 0.66 0.87 1.06 15.98 15.87 0.58 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 5.16 7.90 7.75 6.97 6.13 4.45 0.00 0.00 0.00 0.00 Current Liabilities 220.53 188.76 171.50 157.08 167.52 119.71 149.94 129.06 105.78 99.87 Trade Payables 103.46 97.61 86.51 72.72 86.33 66.71 33.37 30.07 29.95 28.56 Other Current Liabilities 89.28 67.25 54.48 51.95 31.50 30.23 89.93 72.47 58.95 46.11 Short Term Borrowings 20.38 17.60 28.13 27.88 46.39 22.00 21.95 22.30 13.24 21.55 Short Term Provisions 7.41 6.31 2.39 4.53 3.31 0.77 4.68 4.22 3.64 3.64 Total Liabilities 551.24 487.82 427.04 410.94 402.73 284.91 302.52 275.20 239.94 209.35 Net Block 80.27 85.35 88.65 97.57 109.53 99.22 106.22 51.88 53.67 43.44 Gross Block 164.97 158.78 148.81 144.20 140.91 110.99 146.21 86.38 82.89 70.21 Accumulated Depreciation 84.69 73.43 60.03 45.71 31.38 11.76 39.99 34.50 29.22 26.77 Non Current Assets 102.41 112.57 129.01 139.22 147.13 118.35 118.96 109.10 77.07 54.98 Capital Work in Progress 0.19 0.45 8.77 1.54 0.79 0.25 0.85 45.70 1.97 0.31 Non Current Investment 15.13 13.17 8.75 13.05 9.26 8.83 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 6.81 13.62 22.84 27.07 27.55 10.05 11.89 11.52 21.43 11.23 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 448.84 375.25 298.03 271.72 255.61 166.56 183.56 166.10 162.87 154.37 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 10.13 0.13 0.13 0.77 Inventories 78.92 70.30 71.64 55.31 52.90 43.63 41.45 37.38 33.95 27.10 Sundry Debtors 53.58 59.78 76.77 80.25 55.34 34.26 46.62 44.41 38.30 35.10 Cash & Bank 273.51 227.69 132.06 125.62 135.88 82.03 77.16 77.30 84.06 83.76 Other Current Assets 42.83 6.67 5.53 4.72 11.50 6.64 8.19 6.87 6.43 7.64 Short Term Loans & Adv. 11.01 10.80 12.02 5.83 7.58 4.17 7.44 6.12 5.68 6.85 Net Current Assets 228.30 186.48 126.52 114.64 88.09 46.85 33.62 37.04 57.09 54.50 Total Assets 551.25 487.82 427.04 410.94 402.74 284.91 302.52 275.20 239.94 209.35

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 45.00 96.42 19.84 17.31 25.30 17.81 37.35 39.44 12.66 24.35 PBT 57.78 37.05 19.42 39.26 30.15 29.18 35.53 26.33 19.67 21.62 Adjustment 0.26 -2.53 7.18 10.11 13.16 9.52 10.41 10.12 6.16 4.44 Changes in Working Capital -3.86 41.58 4.03 -18.77 -7.35 -12.75 3.58 15.50 -9.26 6.29 Cash after chg. in Working capital 54.18 76.10 30.63 30.59 35.96 25.94 49.53 51.95 16.57 32.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.18 20.32 -10.79 -13.29 -10.66 -8.13 -12.17 -12.51 -3.91 -8.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -30.55 -77.24 -13.30 9.65 -22.56 5.26 -26.73 -49.14 -14.60 -0.52 Net Fixed Assets -5.93 -1.65 -11.84 -4.04 -30.46 35.82 -14.98 -47.22 -14.34 -6.12 Net Investments -1.96 -4.42 4.30 -3.79 -0.43 1.30 -10.00 0.00 0.64 6.00 Others -22.66 -71.17 -5.76 17.48 8.33 -31.86 -1.75 -1.92 -0.90 -0.40 Cash from Financing Activity -9.14 -17.16 -10.17 -30.73 -7.20 -22.94 -10.79 2.91 2.19 -2.04 Net Cash Inflow / Outflow 5.31 2.03 -3.63 -3.77 -4.46 0.13 -0.16 -6.79 0.25 21.79 Opening Cash & Equivalents 9.55 7.53 11.15 14.92 19.04 18.91 76.81 83.60 83.35 61.56 Closing Cash & Equivalent 14.86 9.55 7.53 11.15 14.92 19.04 76.65 76.81 83.60 83.35

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 230.16 205.40 173.09 174.81 161.75 197.09 169.71 146.54 131.87 120.60 ROA 3.56% 8.04% 2.94% 5.99% 5.28% 6.38% 7.85% 6.27% 5.51% 7.07% ROE 6.02% 13.76% 5.01% 10.25% 9.52% 13.16% 18.46% 14.94% 12.64% 16.07% ROCE 8.59% 8.38% 8.28% 15.46% 15.42% 18.63% 23.85% 20.71% 18.12% 22.23% Fixed Asset Turnover 3.70 3.10 4.41 4.40 4.59 4.10 4.46 5.71 5.44 5.94 Receivable days 34.52 52.35 44.37 39.41 28.31 27.96 32.00 31.24 32.18 34.59 Inventory Days 45.45 54.42 35.88 31.45 30.50 29.42 27.71 26.94 26.76 28.54 Payable days 130.35 160.52 50.12 53.93 57.34 40.77 26.81 26.75 29.79 36.84 Cash Conversion Cycle -50.38 -53.76 30.13 16.93 1.47 16.61 32.91 31.43 29.15 26.29 Total Debt/Equity 0.06 0.06 0.12 0.12 0.21 0.15 0.29 0.37 0.31 0.24 Interest Cover 8.67 14.22 6.94 12.62 7.37 10.37 11.68 8.23 7.58 9.50

Top Investors:

axis mutual fund trustee limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

TTK Healthcare reports 23% fall in Q2 net profit
31st Oct 2022, 14:28 PM

Total income of the company increased by 17.82% to Rs 180.85 crore for Q2FY23
Read More
TTK Healthcare - Quarterly Results
28th Oct 2022, 13:18 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback